UNSPSC 51285602: Azacosterol hydrochloride

This classification denotes an enzyme inhibitor and anti-lipidemic agent with the molecular formula C25H44N2O.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B32804UAUQ, chemically known as 20,25-diazacholesterol dihydrochloride but more generally known as azacosterol hydrochloride, which bears US NIH Compound Identifier 14729.

UNSPSC 51285602 Azacosterol hydrochloride is a Commodity code that sees minimal direct solicitation activity under its nominal chemical specification; recent state and local opportunities tagged to this code reflect instead a broader procurement pattern in pharmaceutical and medical supply sourcing across health departments, emergency services, and multistate cooperative purchasing networks. State and local governments buying under related pharmaceutical codes are acquiring generic multi-source drugs, naloxone and emergency medical supplies, and direct-to-manufacturer pharmacy programs through a mix of issuing bodies including state health agencies, county health departments, municipal fire departments, and multistate cooperatives. The Texas Health and Human Services Commission (HHS) and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) represent the state-level actors; Seminole County, Florida and the City of Tampa represent county and municipal purchasers. The scope of work spans competitive bidding for emergency medical consumables and prescription naloxone (Seminole County IFB), sealed bidding for medical and first aid supplies for fire rescue divisions (Tampa ITB), cooperative pharmaceutical contracting through authorized drug wholesalers (MMCAP RFP), and exploratory RFI activity to establish direct-to-manufacturer prescription relationships outside traditional pharmacy benefit manager and group purchasing organization channels (Texas HHS RFI).

Recent activity concentrates in Florida and the Upper Midwest. Seminole County's IFB (due July 26, 2023, though posted June 30, 2026—indicating a date discrepancy in the source) seeks 1,900 units of naloxone and 800 drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building; the City of Tampa's ITB 26P00145 (due March 13, 2026) procures 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division across a $700,000.00 estimated contract value, sheltered exclusively for certified Small Local Business Enterprises with a 5 percent bid discount not to exceed $10,000. The MMCAP RFP (due March 26, 2026) establishes multistate contracts for generic pharmaceuticals and OTC products across participating state and local facilities in Minnesota and Oregon, with awards effective July 1, 2026 and evaluation weighted 75 percent on price competitiveness. The Texas HHS RFI (response deadline April 3, 2026) gathers vendor capabilities for direct-to-manufacturer prescription programs. No award activity or vendor names appear in the source material.